Talc Troubles and the Price of Uncertainty As the global population ages, with nearly a quarter expected to be over 60 by 2050, healthcare spending is skyrocketing.
In the United States alone, this number will swell to 82 million people from just 58 million today. The projected $6 trillion in healthcare spending by 2026 underscores the need for innovative solutions.
Johnson & Johnson (JNJ) has been battling a persistent threat: talc based products allegedly causing ovarian cancer. To settle nearly 80,000 outstanding claims, JNJ is willing to pay $5. 5 billion.